Clinical Trials Directory

Trials / Unknown

UnknownNCT03506191

Pneumonia Due to Stenotrophomonas Maltophilia in ICUs

Pneumonia Due to Stenotrophomonas Maltophilia in Intensive Care Units: a Multicentre Retrospective Study

Status
Unknown
Phase
Study type
Observational
Enrollment
300 (estimated)
Sponsor
Groupe Hospitalier Pitie-Salpetriere · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Pneumonia is a major cause of ICU admission, or may complicate ICU course. Among the causative pathogens, Stenotrophomonas Maltophilia is a rare pathogen, but affects usually patients with chronic pulmonary co-morbidities, or with long duration of mechanical ventilation and multiples treatment with broad spectrum antimicrobial therapy. However, there are only a paucity of data regarding epidemiology, impact and outcome of Pneumonia due to Stenotrophomonas Maltophilia in critically ill patients. Primary objective was to study factors associated with mortality in case of Pneumonia due to Stenotrophomonas Maltophilia. Secondary objectives were to describe factors associated with morbidity of Pneumonia due to Stenotrophomonas Maltophilia (duration of mechanical ventilation, ICU length of stay), and to report the characteristics of critically ill patients presenting Pneumonia due to Stenotrophomonas Maltophilia.

Conditions

Timeline

Start date
2017-01-01
Primary completion
2018-07-30
Completion
2018-09-30
First posted
2018-04-24
Last updated
2018-08-01

Locations

4 sites across 1 country: France

Source: ClinicalTrials.gov record NCT03506191. Inclusion in this directory is not an endorsement.